First clinical trial of innovative drug targeting HSF1 pathway begins 31 Dec 2021 The first cancer patients are to receive doses of an innovative new drug that targets a master regulatory pathway in cells, as part of a new clinical trial. Find out more Show/Hide
Researchers find immune system link with rare ovarian cancer that could guide future treatment 14 Oct 2021 Immune-related genes are associated with the development of the rare cancer ovarian clear cell carcinoma (OCCC), new research has found. Find out more Show/Hide
Innovative ICR-discovered drug to enter first clinical trial, targeting HSF1 pathway 26 Aug 2021 Cancer patients are set to receive, for the first time, a highly innovative investigational drug called NXP800 – which was discovered at The Institute of Cancer Research, London. Find out more Show/Hide